 Jeffrey Brent
Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Poisoning | 16 | 2023 | 110 | 2.730 |
Why?
| | Drug Overdose | 13 | 2023 | 292 | 1.450 |
Why?
| | Registries | 27 | 2024 | 1768 | 1.440 |
Why?
| | Toxicology | 10 | 2023 | 35 | 1.420 |
Why?
| | Decontamination | 2 | 2014 | 23 | 0.880 |
Why?
| | Burns, Chemical | 2 | 2014 | 25 | 0.880 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 7 | 2018 | 238 | 0.840 |
Why?
| | Mesothelioma | 1 | 2023 | 31 | 0.840 |
Why?
| | Butterflies | 1 | 2023 | 21 | 0.830 |
Why?
| | Moths | 1 | 2023 | 35 | 0.820 |
Why?
| | Snake Bites | 5 | 2022 | 54 | 0.800 |
Why?
| | Analgesics, Opioid | 11 | 2023 | 771 | 0.770 |
Why?
| | Acidosis | 1 | 2022 | 88 | 0.730 |
Why?
| | Skin | 2 | 2014 | 655 | 0.650 |
Why?
| | Metformin | 1 | 2022 | 276 | 0.620 |
Why?
| | Metal-on-Metal Joint Prostheses | 1 | 2017 | 2 | 0.590 |
Why?
| | Chromium | 1 | 2017 | 12 | 0.580 |
Why?
| | Hypoglycemia | 1 | 2022 | 387 | 0.570 |
Why?
| | Cobalt | 1 | 2017 | 46 | 0.570 |
Why?
| | Hip Prosthesis | 1 | 2017 | 33 | 0.570 |
Why?
| | Emergency Service, Hospital | 11 | 2023 | 1820 | 0.520 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2017 | 109 | 0.510 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 900 | 0.450 |
Why?
| | Decision Support Techniques | 1 | 2017 | 355 | 0.430 |
Why?
| | United States | 23 | 2023 | 12186 | 0.410 |
Why?
| | Referral and Consultation | 7 | 2020 | 635 | 0.390 |
Why?
| | Paraquat | 1 | 2011 | 14 | 0.390 |
Why?
| | Herbicides | 1 | 2011 | 24 | 0.380 |
Why?
| | Parkinsonian Disorders | 1 | 2011 | 28 | 0.380 |
Why?
| | Antivenins | 4 | 2022 | 56 | 0.370 |
Why?
| | Hallucinogens | 2 | 2023 | 73 | 0.360 |
Why?
| | Fentanyl | 4 | 2023 | 65 | 0.340 |
Why?
| | Analgesics, Non-Narcotic | 3 | 2023 | 120 | 0.340 |
Why?
| | Humans | 49 | 2024 | 114709 | 0.320 |
Why?
| | Young Adult | 17 | 2023 | 10472 | 0.320 |
Why?
| | Aged | 18 | 2023 | 19074 | 0.310 |
Why?
| | Middle Aged | 21 | 2023 | 26738 | 0.310 |
Why?
| | Adult | 25 | 2023 | 30554 | 0.300 |
Why?
| | Adolescent | 20 | 2023 | 17855 | 0.300 |
Why?
| | Child | 21 | 2023 | 18422 | 0.300 |
Why?
| | Child, Preschool | 16 | 2023 | 9119 | 0.290 |
Why?
| | Cannabinoids | 2 | 2021 | 115 | 0.280 |
Why?
| | Substance-Related Disorders | 4 | 2020 | 947 | 0.270 |
Why?
| | Male | 27 | 2023 | 55609 | 0.250 |
Why?
| | Cannabis | 2 | 2023 | 384 | 0.250 |
Why?
| | Time Factors | 7 | 2020 | 6116 | 0.250 |
Why?
| | Edema | 2 | 2023 | 119 | 0.240 |
Why?
| | Infant | 12 | 2020 | 7964 | 0.230 |
Why?
| | Female | 29 | 2023 | 59523 | 0.230 |
Why?
| | Adenosine Monophosphate | 1 | 2024 | 49 | 0.220 |
Why?
| | Substance Abuse Detection | 2 | 2021 | 62 | 0.220 |
Why?
| | Plant Poisoning | 1 | 2023 | 9 | 0.220 |
Why?
| | Alanine | 1 | 2024 | 104 | 0.220 |
Why?
| | Prospective Studies | 11 | 2023 | 6220 | 0.220 |
Why?
| | Talc | 1 | 2023 | 5 | 0.220 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2023 | 27 | 0.220 |
Why?
| | Opioid-Related Disorders | 2 | 2021 | 413 | 0.220 |
Why?
| | Treatment Outcome | 8 | 2020 | 9088 | 0.210 |
Why?
| | Psychotropic Drugs | 4 | 2023 | 54 | 0.210 |
Why?
| | Foodborne Diseases | 1 | 2023 | 45 | 0.210 |
Why?
| | Methadone | 2 | 2020 | 77 | 0.200 |
Why?
| | Ivermectin | 1 | 2022 | 9 | 0.200 |
Why?
| | Tramadol | 1 | 2022 | 10 | 0.200 |
Why?
| | Larva | 1 | 2023 | 194 | 0.200 |
Why?
| | Snakes | 2 | 2022 | 20 | 0.200 |
Why?
| | Narcotics | 1 | 2022 | 44 | 0.200 |
Why?
| | Vertigo | 1 | 2022 | 37 | 0.200 |
Why?
| | Sulfonylurea Compounds | 1 | 2022 | 44 | 0.190 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 54 | 0.190 |
Why?
| | Tremor | 1 | 2022 | 45 | 0.190 |
Why?
| | Nausea | 1 | 2022 | 101 | 0.190 |
Why?
| | Dizziness | 1 | 2022 | 70 | 0.190 |
Why?
| | Narcotic Antagonists | 2 | 2022 | 136 | 0.190 |
Why?
| | Antidotes | 3 | 2023 | 135 | 0.190 |
Why?
| | Vomiting | 1 | 2022 | 123 | 0.190 |
Why?
| | Metals, Heavy | 1 | 2021 | 19 | 0.190 |
Why?
| | Prescription Drug Misuse | 1 | 2021 | 38 | 0.180 |
Why?
| | Diarrhea | 1 | 2022 | 171 | 0.180 |
Why?
| | Abdominal Pain | 1 | 2022 | 135 | 0.180 |
Why?
| | Research Personnel | 4 | 2022 | 149 | 0.180 |
Why?
| | Elapid Venoms | 1 | 2020 | 15 | 0.180 |
Why?
| | Coral Snakes | 1 | 2020 | 2 | 0.180 |
Why?
| | Benzodiazepines | 1 | 2021 | 116 | 0.180 |
Why?
| | Eating | 1 | 2023 | 344 | 0.180 |
Why?
| | Creatinine | 1 | 2022 | 425 | 0.180 |
Why?
| | Crotalus | 1 | 2020 | 18 | 0.170 |
Why?
| | Cocaine | 1 | 2022 | 153 | 0.170 |
Why?
| | Cohort Studies | 8 | 2023 | 4895 | 0.170 |
Why?
| | Crotalid Venoms | 1 | 2020 | 31 | 0.170 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 288 | 0.170 |
Why?
| | Antidepressive Agents | 3 | 2016 | 195 | 0.160 |
Why?
| | Loperamide | 1 | 2018 | 10 | 0.160 |
Why?
| | Antidiarrheals | 1 | 2018 | 15 | 0.160 |
Why?
| | Annual Reports as Topic | 1 | 2018 | 5 | 0.160 |
Why?
| | Retrospective Studies | 5 | 2024 | 12556 | 0.160 |
Why?
| | Crime | 1 | 2019 | 59 | 0.160 |
Why?
| | Aged, 80 and over | 7 | 2019 | 6347 | 0.150 |
Why?
| | Viperidae | 1 | 2018 | 11 | 0.150 |
Why?
| | Israel | 2 | 2017 | 40 | 0.150 |
Why?
| | Animals | 8 | 2023 | 31709 | 0.150 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2018 | 69 | 0.150 |
Why?
| | Drug Misuse | 1 | 2017 | 1 | 0.150 |
Why?
| | London | 1 | 2017 | 43 | 0.140 |
Why?
| | Crime Victims | 1 | 2019 | 80 | 0.140 |
Why?
| | Prosthesis Failure | 1 | 2017 | 115 | 0.130 |
Why?
| | Designer Drugs | 1 | 2016 | 8 | 0.130 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2018 | 159 | 0.130 |
Why?
| | Risk Factors | 4 | 2017 | 8634 | 0.130 |
Why?
| | Naloxone | 3 | 2022 | 97 | 0.130 |
Why?
| | Prognosis | 3 | 2020 | 3330 | 0.130 |
Why?
| | Chronic Pain | 1 | 2019 | 210 | 0.130 |
Why?
| | North America | 3 | 2022 | 256 | 0.120 |
Why?
| | Hospitalization | 4 | 2022 | 1752 | 0.120 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 134 | 0.120 |
Why?
| | Odds Ratio | 1 | 2017 | 953 | 0.120 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1013 | 0.120 |
Why?
| | Tertiary Care Centers | 1 | 2015 | 126 | 0.110 |
Why?
| | Reproducibility of Results | 2 | 2021 | 2765 | 0.110 |
Why?
| | Hydrofluoric Acid | 1 | 2013 | 8 | 0.110 |
Why?
| | Hospital Mortality | 3 | 2023 | 776 | 0.110 |
Why?
| | Poison Control Centers | 2 | 2015 | 84 | 0.110 |
Why?
| | Australia | 1 | 2013 | 206 | 0.110 |
Why?
| | International Cooperation | 1 | 2013 | 171 | 0.110 |
Why?
| | Alanine Transaminase | 2 | 2024 | 142 | 0.110 |
Why?
| | Pharmacovigilance | 2 | 2023 | 14 | 0.100 |
Why?
| | Data Mining | 1 | 2013 | 100 | 0.100 |
Why?
| | Canada | 1 | 2013 | 322 | 0.100 |
Why?
| | Organic Chemicals | 1 | 2013 | 112 | 0.100 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1796 | 0.100 |
Why?
| | Coma | 2 | 2023 | 30 | 0.100 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 480 | 0.090 |
Why?
| | Prevalence | 1 | 2017 | 2251 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2013 | 381 | 0.090 |
Why?
| | Pediatrics | 2 | 2018 | 981 | 0.090 |
Why?
| | Pregnancy Complications | 1 | 2015 | 429 | 0.090 |
Why?
| | Water | 1 | 2013 | 396 | 0.090 |
Why?
| | Compensation and Redress | 1 | 2010 | 7 | 0.090 |
Why?
| | Consultants | 1 | 2010 | 13 | 0.090 |
Why?
| | Societies, Medical | 1 | 2013 | 664 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2540 | 0.080 |
Why?
| | Infant, Newborn | 3 | 2020 | 5047 | 0.080 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 932 | 0.080 |
Why?
| | Length of Stay | 1 | 2013 | 962 | 0.080 |
Why?
| | Survivors | 1 | 2011 | 411 | 0.080 |
Why?
| | Biomarkers | 1 | 2017 | 3408 | 0.070 |
Why?
| | Databases, Factual | 3 | 2017 | 1125 | 0.070 |
Why?
| | Outpatients | 2 | 2021 | 326 | 0.060 |
Why?
| | Health Personnel | 1 | 2010 | 574 | 0.060 |
Why?
| | Inpatients | 2 | 2021 | 380 | 0.060 |
Why?
| | Xylazine | 1 | 2023 | 6 | 0.050 |
Why?
| | Attitude of Health Personnel | 1 | 2010 | 975 | 0.050 |
Why?
| | Phenacetin | 1 | 2022 | 1 | 0.050 |
Why?
| | Alprazolam | 1 | 2022 | 6 | 0.050 |
Why?
| | Codeine | 1 | 2022 | 7 | 0.050 |
Why?
| | Bradycardia | 1 | 2023 | 48 | 0.050 |
Why?
| | Age Factors | 2 | 2020 | 2894 | 0.050 |
Why?
| | Levamisole | 1 | 2022 | 20 | 0.050 |
Why?
| | Heroin | 1 | 2022 | 23 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2023 | 172 | 0.050 |
Why?
| | Chloroquine | 1 | 2022 | 52 | 0.050 |
Why?
| | Heavy Metal Poisoning | 1 | 2021 | 2 | 0.050 |
Why?
| | Benzimidazoles | 1 | 2022 | 138 | 0.050 |
Why?
| | Chelating Agents | 1 | 2021 | 65 | 0.050 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 30 | 0.040 |
Why?
| | Paresthesia | 1 | 2020 | 10 | 0.040 |
Why?
| | Erythema | 1 | 2020 | 25 | 0.040 |
Why?
| | Antiemetics | 1 | 2020 | 32 | 0.040 |
Why?
| | Texas | 1 | 2020 | 188 | 0.040 |
Why?
| | Emergency Treatment | 1 | 2021 | 113 | 0.040 |
Why?
| | Ethanol | 1 | 2023 | 538 | 0.040 |
Why?
| | Weapons of Mass Destruction | 1 | 2018 | 1 | 0.040 |
Why?
| | Risk Assessment | 2 | 2019 | 2968 | 0.040 |
Why?
| | Atrioventricular Block | 1 | 2018 | 37 | 0.040 |
Why?
| | Pregnancy | 2 | 2023 | 5520 | 0.040 |
Why?
| | Critical Illness | 1 | 2023 | 646 | 0.040 |
Why?
| | Antiviral Agents | 1 | 2024 | 645 | 0.040 |
Why?
| | Opiate Substitution Treatment | 1 | 2019 | 98 | 0.040 |
Why?
| | Intubation, Intratracheal | 1 | 2020 | 216 | 0.040 |
Why?
| | Long QT Syndrome | 1 | 2018 | 59 | 0.040 |
Why?
| | Retreatment | 1 | 2017 | 67 | 0.040 |
Why?
| | Demography | 1 | 2018 | 260 | 0.040 |
Why?
| | Toxiferine | 1 | 2016 | 1 | 0.030 |
Why?
| | Respiratory Insufficiency | 1 | 2020 | 290 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 279 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2381 | 0.030 |
Why?
| | Sentinel Surveillance | 1 | 2016 | 38 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 665 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 165 | 0.030 |
Why?
| | Societies, Scientific | 1 | 2016 | 47 | 0.030 |
Why?
| | Buprenorphine | 1 | 2019 | 134 | 0.030 |
Why?
| | Patient Admission | 1 | 2017 | 176 | 0.030 |
Why?
| | Electrocardiography | 1 | 2018 | 560 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1320 | 0.030 |
Why?
| | Pain | 1 | 2020 | 705 | 0.030 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 68 | 0.030 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2015 | 79 | 0.030 |
Why?
| | Suicide, Attempted | 1 | 2016 | 317 | 0.030 |
Why?
| | Program Evaluation | 1 | 2017 | 822 | 0.030 |
Why?
| | Acute Disease | 1 | 2015 | 911 | 0.030 |
Why?
| | Oxycodone | 1 | 2012 | 44 | 0.030 |
Why?
| | Acetylcysteine | 1 | 2012 | 141 | 0.020 |
Why?
| | Health Promotion | 1 | 2017 | 686 | 0.020 |
Why?
| | Cardiovascular Agents | 1 | 2012 | 126 | 0.020 |
Why?
| | Anticonvulsants | 1 | 2012 | 179 | 0.020 |
Why?
| | Antipsychotic Agents | 1 | 2012 | 184 | 0.020 |
Why?
| | Acetaminophen | 1 | 2012 | 241 | 0.020 |
Why?
| | Data Collection | 1 | 2011 | 620 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2015 | 590 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2010 | 4624 | 0.010 |
Why?
|
|
Brent's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|